Zurich Cantonal Bank
OSIR

Zurich Cantonal Bank’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Zurich Cantonal Bank’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-729
Closed -$4K – 2611
2016
Q1 		$4K Hold
729
– – ﹤0.01% 2541
2015
Q4 		$8K Buy
+729
New +$9.89K ﹤0.01% 2470

Other funds holding OSIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
QI
QS Investors New York $8.47B AUM 30.71% 1-Year Est. Return

Zurich Cantonal Bank's OSIR Position: Q2 2016 in Review

Zurich Cantonal Bank sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2016, closing a stake of 729 shares — an estimated $4K sold.

Zurich Cantonal Bank first reported a position in OSIR in Q4 2015 and held it in 2 quarters. The position peaked at $8K in Q4 2015. 68 funds tracked by Wall St. Rank hold OSIR as of Q2 2016.

  • Zurich Cantonal Bank reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
  • Zurich Cantonal Bank sold 729 Osiris Therapeutics, Inc. Common Stock shares in Q2 2016, an estimated $4K.
  • Zurich Cantonal Bank first reported a position in Osiris Therapeutics, Inc. Common Stock in Q4 2015 and held it in 2 quarters.
  • Zurich Cantonal Bank's Osiris Therapeutics, Inc. Common Stock position peaked at $8K in Q4 2015.
  • 68 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2016.

Based on Zurich Cantonal Bank's 13F filing for Q2 2016, filed 1 Aug 2016.